Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literature
Kaygusuz Atagündüz, Işık
Fıratlı Tuğlular, Tulin
MetadataShow full item record
CitationKantarcıoğlu, B., Kaygusuz Atagündüz, I., Uzay, A., Toptaş, T., Fıratlı Tuğlular, T. ve Bayık, M. (2015). Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literature. International Journal of Hematology, 102(3), 383-387. https://dx.doi.org/10.1007/s12185-015-1792-2
The human JAK2 gene is mainly targeted by two types of genetic lesions that play roles in the pathogenesis of hematologic malignancies: intragenic mutations and chromosomal translocations. Chromosomal translocations of JAK2 are typically associated with myeloid or lymphoid malignancies with an aggressive course and poor outcome. Here we report a t(9;22)(p24;q11.2) translocation, in a MDS patient and review results associated with BCR-JAK2 fusion reported in the literature.